In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MedChannel

www.medchannel.com

Latest From MedChannel

Novation's E-Commerce Play

One of the last of the major hospital groups to commit to an Internet strategy, Novation has leaped into e-commerce with both feet through its recent deal with Neoforma. The company faces a host of challenges, not the least of which come from uncertain hospitals and reluctant product companies. For suppliers, the alliance of leading groups and dot-com companies raises questions about the future of the hospital marketplace.
Business Strategies Reimbursement

Cardinal.com: The New Old Thing

Often overlooked in the debate over who's going to win the Internet wars, Cardinal makes its case for a distributor-driven model. A single place to purchase drugs and med/surg supplies, do remote order entry, and more efficiently process information, Cardinal.com builds off of traditional EDI programs. Like many e-commerce plays, Cardinal.com recognizes the value of an open system and the ability to work with as wide a variety of sites as the customer wants. But company officials make a distinction between a stance of openness and neutrality. In the process, Cardinal is trying to make the argument that rather than being disintermediated by the new B2B players, distribution-based models may ultimately prove the most robust and sustainable because of distributors' history of supply chain management.
Medical Device Business Strategies

The New Internet Supply Chain: Issues for Device and Supply Companies

B2B e-commerce players promised early on to help smaller product companies level the playing field in competing against the entrenched interests of big suppliers and GPOs. But large suppliers with established relationships with GPOs and national distributors are likely to push B2Bs away from creating a more open market.
Medical Device Strategy

Transactions 1999: Dealmaking for the New Economy

The number of early-stage deals plummeted as large drug companies fought their way through mergers and other late-stage deals designed to boost near-term earnings. Drug companies also looked to mergers to build up sales forces and, by building bigger-selling products, to compensate for the lack of R&D productivity. Meanwhile, biotechs, with valuations at record levels, looked to find deals that would allow them to keep the upside of their products and move their share prices up.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Digital Health
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • MedChannel
  • Senior Management
  • Contact Info
  • MedChannel
    Phone: (415) 487-3456
    650 Townsend Street, Ste. #315
    San Francisco, CA 94103
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register